MODV (ModivCare) Change In Receivables : $19 Mil (TTM As of Dec. 2024)

View and export this data going back to 2003. Start your Free Trial

What is ModivCare Change In Receivables?

ModivCare's change in receivables for the quarter that ended in Dec. 2024 was $19 Mil. It means ModivCare's Accounts Receivable declined by $19 Mil from Sep. 2024 to Dec. 2024 .

ModivCare's change in receivables for the fiscal year that ended in Dec. 2024 was $19 Mil. It means ModivCare's Accounts Receivable declined by $19 Mil from Dec. 2023 to Dec. 2024 .

ModivCare's Accounts Receivable for the quarter that ended in Dec. 2024 was $222 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. ModivCare's Days Sales Outstanding for the three months ended in Dec. 2024 was 28.87.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. ModivCare's liquidation value for the three months ended in Dec. 2024 was $-1,413 Mil.

ModivCare Change In Receivables Historical Data

The historical data trend for ModivCare's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ModivCare Change In Receivables Chart

ModivCare Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

52.36

-13.75

-55.78

-78.10

18.73

ModivCare Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Change In Receivables	Get a 7-Day Free Trial															-34.20	-7.14	-27.38	34.05	19.20

ModivCare Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $19 Mil.

ModivCare (NAS:MODV) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

ModivCare's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	222.317	/	702.799	*	91
=	28.87

2. In Ben Graham's calculation of liquidation value, ModivCare's accounts receivable are only considered to be worth 75% of book value:

ModivCare's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	112.581	-	1692.806	+	0.75 * 222.317	+	0.5 * 0
=	-1,413

ModivCare Change In Receivables Related Terms

Thank you for viewing the detailed overview of ModivCare's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

ModivCare Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » ModivCare Inc (NAS:MODV) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

PRF0:Germany PRF0:Germany

Address

6900 E Layton Avenue, 12th Floor, Denver, CO, USA, 80237

Website

https://www.modivcare.com

ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. Its solutions address the social determinants of health (SDoH) by connecting members to essential care services. Its various service offerings include non-emergency medical transportation, personal care, virtual and remote monitoring, consumer health engagement, and integrated supportive care. The company's reportable segments are NEMT, PCS, Monitoring, and Corporate and Other. A majority of its revenue is generated from the NEMT segment, which provides non-emergency medical transportation services.

Executives

Coliseum Capital Management, Llc	director, 10 percent owner	105 ROWAYTON AVENUE, ROWAYTON CT 06853
Barbara Gutierrez	officer: Chief Financial Officer	8950 E. LOWRY BLVD., DENVER CO 80230
L Heath Sampson	officer: Chief Financial Officer	C/O ADVANCED EMISSIONS SOLUTIONS, INC., 9135 S RIDGELINE BLVD STE 200, HIGHLANDS RANCH CO 80129
Henry Toledo	officer: Chief People Officer	6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Jessica Kral	officer: Chief Information Officer	6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Anne E, Bailey	officer: President, Home Division	6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Rebecca Orcutt	officer: VP, Chief Accounting Officer	6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Brett M. Hickman	officer: Chief Commercial Officer	6900 LAYTON AVENUE, SUITE 1200, DENVER CO 80237
Ilias Simpson	officer: President, Transportation	6900 LAYTON AVENUE, SUITE 1200, DENVER CO 80237
Jason E Anderson	officer: President of ModivCare Home	6900 LAYTON AVENUE, SUITE 1200, DENVER CO 80237
Grover Wray	officer: Chief Human Resources Officer	DIGITALGLOBE, INC., 1300 WEST 120TH AVENUE, WESTMINSTER CO 80234
Daniel E Greenleaf	director, officer: CEO and President	C/O NABI BIO PHARMACEUTICALS, 5800 PARK OF COMMERCE BLVD., N.W., BOCA RATON FL 33487
Jonathan B Bush	officer: SVP, GC and Secretary	6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Kenneth Shepard	officer: Vice President, CAO	6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Stacy Saal	director	4700 SOUTH SYRACUSE STREET, 4TH FLOOR, DENVER CO 80237